Speak with one of our experts to learn how you can license CD8 ImmunoPET™ in your clinical trials.

news
Publications

'What Pharma Wants' survey summary

31 Aug 2022

news
BD Newsletter

July Edition 2022

28 Jul 2022

news
ImaginAb Data
Case Studies
Abstract Presentations

Preclinical: Pet imaging of cytotoxic human T cells using an 89Zr-labeled anti-CD8 minibody

12 May 2022

news
Publications
Abstract Presentations

Arming antibodies: prospects and challenges for immunoconjugates

08 Jun 2021

news
Publications
Abstract Presentations

Antibodies for molecular imaging of cancer

08 Jun 2021

news
ImaginAb Data
Publications
Abstract Presentations

Preclinical: Positive progress in immunoPET - not just a coincidence

08 Jun 2021

news
ImaginAb Data
Case Studies
Abstract Presentations

Preclinical: Development of an ImmunoPET Tracer for Imaging Human CD8+ T Cells

08 Jun 2021

news
ImaginAb Data
Case Studies
Abstract Presentations

Preclinical: Anti-CD8 immunoPET detection of CD8+ tumor infiltrating lymphocytes

08 Jun 2021

news
ImaginAb Data
Case Studies
Abstract Presentations

Preclinical: PET Imaging of Cytotoxic Human T Cells Using an 89Zr-Labeled Anti-CD8 Minibody

08 Jun 2021

Speak with one of our experts to learn how you can license CD8 ImmunoPET™ in your clinical trials.